K

Kiniksa Pharmaceuticals Ltd
D

KNSA

21.830
USD
0.54
(2.54%)
مفتوح الان
حجم التداول
5,386
الربح لكل سهم
0
العائد الربحي
-
P/E
-182
حجم السوق
1,576,160,164
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.